Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium

from Deep Margin · host Dr Ben O'Leary and Dr Will Ince

Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.

Episode metadata supplied by the publisher feed · Published May 31, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium

0:00 39:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Deep Margin?

This episode is 39 minutes long.

When was this Deep Margin episode published?

This episode was published on May 31, 2026.

Can I download this Deep Margin episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!